Document is current
Any future updates will be listed below
-
Authors
Hungria, Vania
Moura, Fernanda Lemos
Costa, Abel
Ribeiro, Eduardo Flávio Oliveira
Soares, Paulo
Lima, Juliana Souza
Ricci, Lisa Aquaroni
Arrais-Rodrigues, Celso
Nucci, Fabio Moore
de Moraes Lima, Marinus
de Magalhães Filho, Roberto Jose Pessoa
Bhaumik, Amitabha
Parekh, Trilok
Borgsten, Fredrik
Carson, Robin
Trufelli, Damila C.
de Queiroz Crusoe, Edvan
-
Funding
Funding for this research was provided by:
Johnson & Johnson
- License Information
-
More Information
Article History
Received: 28 January 2025
Accepted: 8 April 2025
First Online: 30 April 2025
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: Vania Hungria has received honoraria from AbbVie, Amgen, Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Regeneron, Sanofi, and Takeda. Fernanda Lemos Moura has received institutional research funding from Bristol Myers Squibb, Johnson & Johnson, Pfizer, and Takeda; served as aconsultant for Amgen, Johnson & Johnson, Pfizer, and Sanofi; and has received honoraria for speaker and/or scientific conference participation from Amgen, Bristol Myers Squibb, Johnson & Johnson, Pfizer, Sanofi, and Takeda. Abel Costa has received honoraria from AbbVie, AstraZeneca, BeiGene, Johnson & Johnson, Knight Therapeutics, Lilly, Regeneron, and Roche. Eduardo Flávio Oliveira Ribeiro has received honoraria from AbbVie, AstraZeneca, Johnson & Johnson, Lilly, and Sanofi. Fabio Moore Nucci has received honoraria for speaker activities from AbbVie, AstraZeneca, and Johnson & Johnson; and institutional research funding from BeiGene, GSK, and Johnson & Johnson. Marinus de Moraes Lima has received honoraria from AbbVie, BeiGene, Johnson & Johnson, and Takeda. Roberto Jose Pessoa de Magalhães Filho has served as a consultant for and received honoraria for advisory board participation from Amgen, Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, and Sanofi; and received institutional research funding from Bristol Myers Squibb, Pfizer, and Regeneron. Amitabha Bhaumik, Trilok Parekh, Fredrik Borgsten, and Robin Carson are employees of Johnson & Johnson and may hold stock in Johnson & Johnson. Damila C. Trufelli is an employee of Johnson & Johnson. Edvan de Queiroz Crusoe has received institutional research funding from Johnson & Johnson and honoraria from Amgen, GSK, Johnson & Johnson, Pfizer, Sanofi, and Takeda. Paulo Soares, Juliana Souza Lima, Lisa Aquaroni Ricci, and Celso Arrais-Rodrigues have no conflicts of interest to disclose.
